JBT Marel (JBTM) Q2 2026 Earnings Call Transcript
JBT Marel (JBTM) reported Q2 2026 revenue of $981 million, up 5% YoY, with Protein Solutions at $467 million (+11%) and Prepared Food and Beverage Solutions at $514 million (flat). Adjusted EBITDA was $168 million (17.1% margin) and adjusted diluted EPS was $1.95. Inbound orders were $1.03 billion and backlog $1.54 billion. Full-year revenue guidance is $3.99B to $4.065B.
How this was made
The 30-second read
Why it matters
Key trading inputs are maintained full-year revenue and margin guidance, strong inbound orders and backlog, and management commentary on margin pressure from inflation/logistics plus a planned Q4 production ramp.
Market read
Traders can update models using the provided guidance ranges, backlog/book-to-bill, and margin drivers, then weigh them against segment-specific headwinds (logistics delays, beef-side inventory constraints).
What to watch
The guidance includes a foreign-exchange headwind and logistics spending tied to inbound and intercompany transport, which may pressure cash conversion if cost recovery worsens.
Background
The text is an earnings call transcript for JBT Marel covering Q2 2026 performance, integration progress, and full-year guidance.
Ticker impact
JBT Marel reported Q2 2026 results and reiterated full-year revenue guidance of $3.99B to $4.065B with EBITDA margin guidance of 17.0% to 17.5%.
Moderate volatility around guidance interpretation, with upside bias if investors focus on backlog visibility and margin expansion.
The article provides multiple concrete datapoints (EPS, EBITDA margin, backlog, book-to-bill, and full-year guidance) that can reframe expectations, but it is a transcript recap rather than a clearly first-time market-moving disclosure beyond the earnings release itself.
Market effects
Signals continued capex and automation demand in poultry processing equipment, with margin sensitivity to logistics and input costs.
Mentions footprint optimization across Eastern Europe, Brazil, and India, implying operational restructuring benefits may be regionally distributed.
Backlog visibility for more than 90% of equipment revenue into H2 2026 supports global demand confidence for protein value-chain automation.
Counterpoint
Beef-side weakness and production delays in Prepared Food and Beverage could cause the Q4 ramp to underdeliver versus the implied efficiency narrative.
Key entities
- companyJBT Marel
Protein solutions and prepared foods solutions provider reporting Q2 2026 results, backlog, and full-year guidance.
- executiveBrian Deck
CEO discussing demand environment, segment positioning, and Q4 ramp expectations.
- executiveMatthew Meister
CFO citing inflationary logistics and input-cost pressure and explaining margin dynamics.
